Emmis Acquisition (EMIS) vs NovaBridge Biosciences (NBP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Emmis Acquisition is the larger company by market cap ($162.0 million vs $158.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EMIS | NBP |
|---|---|---|
| Share price | $10.27 | $1.37 |
| Market cap | $162.02M | $158.34M |
| 1-day change | 0.00% | -0.36% |
| YTD return | +3.22% | -65.58% |
| 1-year return | — | -68.65% |
| 5-year return | — | -97.92% |
| EPS (TTM) | — | $-0.69 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.27 | $6.79 |
| 52-week low | $9.90 | $1.31 |
| Distance from 52-week high | 0.00% | -79.90% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +559.34% |
| Average volume | 13.67K | 387.00K |
| Shares outstanding | 11.94M | 116.00M |
| Employees | — | 30 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Emmis Acquisition
EMIS stock →Emmis Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
Health Care · Biotechnology: Pharmaceutical Preparations
About NovaBridge Biosciences
NBP stock →NovaBridge Biosciences, a biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and Ophthalmology.
Health Care · Biotechnology: Pharmaceutical Preparations · 30 employees
EMIS vs NBP FAQ
Which is bigger, Emmis Acquisition or NovaBridge Biosciences?
Emmis Acquisition (EMIS) is larger, with a market capitalization of $162.02M compared with $158.34M for NovaBridge Biosciences (NBP).
Are Emmis Acquisition and NovaBridge Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.